Fundraising Fox

CirculoGene Theranostics

Birmingham, US · Founded 2015 · Delaware corporation

Founders & leadership

MV
Michael V. MullenExecutive
SR
Scott RezekExecutive
CY
Chen YehNamed on SEC filing

Board

CC
Charles ClarkBoard director
EF
Edwin FinchBoard director

Reported raises · per SEC filings

Form D private placements

$10.9M disclosed across 10 rounds · 2015–2023

$2MraisedMar 2023 · 1 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Richard BrandExecutive Officer
  • Mike MullenExecutive Officer
Offering amount
$5M
Amount sold
$2M
Placement agents
Arcadia Securities, LLC
First sale
Mar 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$2.6MraisedSep 2022 · 9 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Richard BrandExecutive Officer
  • Mike MullenExecutive Officer
Offering amount
$5M
Amount sold
$2.6M
Placement agents
Arcadia Securities, LLC
First sale
Jul 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$250KraisedJan 2021 · 1 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Charles A. MusialExecutive Officer
  • Michael V. MullenExecutive Officer, Director
  • Harold B. DunnDirector
  • Daniel ColemanDirector
  • Thomas A. SatterfieldDirector
  • Chen-Hsiung YehExecutive Officer
  • Stephen EckDirector
  • Robert GarvieDirector
  • Scott RezekExecutive Officer
  • James E. CantrellDirector
Offering amount
$15M
Amount sold
$250K
Finders' fees
$17.5K
Placement agents
Arcadia Securities, LLC
First sale
Jan 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$330KraisedSep 2019 · 6 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Michael V MullenExecutive Officer, Director
  • Edwin FinchDirector
  • Charles ClarkDirector
  • Chen YehExecutive Officer
  • Scott RezekExecutive Officer
  • Stephen EckDirector
  • Daniel ColemanDirector
  • Robert GarvieDirector
Offering amount
$2M
Amount sold
$330K
First sale
Sep 2019
Incorporated
Limited Liability Company, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$2MraisedNov 2018 · 6 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Chen YehExecutive Officer
  • Charles ClarkDirector
  • Robert GarvieDirector
  • Michael V MullenExecutive Officer, Director
  • Scott RezekExecutive Officer
  • Stephen EckDirector
  • Edwin FinchDirector
  • Daniel ColemanDirector
Offering amount
$3M
Amount sold
$2M
Minimum investment
$50K
First sale
Nov 2018
Incorporated
Limited Liability Company, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$1MraisedJan 2018 · 6 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Scott RezekExecutive Officer
  • Michael V MullenExecutive Officer, Director
  • Edwin W FinchDirector
  • Chen YehExecutive Officer
  • Charles ClarkDirector
Offering amount
$3M
Amount sold
$1M
First sale
Jan 2018
Incorporated
Limited Liability Company, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$350KraisedSep 2017 · 6 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Chen YehExecutive Officer
  • Charles ClarkDirector
  • Michael V. MullenExecutive Officer, Director
  • Edwin W. FinchDirector
  • Scott RezekExecutive Officer
Offering amount
$700K
Amount sold
$350K
First sale
Sep 2017
Incorporated
Limited Liability Company, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$355KraisedMar 2017 · 5 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Edwin FinchDirector
  • Chen YehExecutive Officer
  • Scott RezekExecutive Officer
  • Michael V. MullenExecutive Officer, Director
  • Charles ClarkDirector
Offering amount
$800K
Amount sold
$355K
First sale
Mar 2017
Incorporated
Limited Liability Company, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

How much funding has CirculoGene Theranostics raised?
CirculoGene Theranostics has disclosed $10.9M raised across 10 rounds.
Where is CirculoGene Theranostics headquartered?
CirculoGene Theranostics is headquartered in Birmingham, US.